Clinical Focus ›› 2024, Vol. 39 ›› Issue (12): 1106-1110.doi: 10.3969/j.issn.1004-583X.2024.12.008
Previous Articles Next Articles
Wang Hongqian1, Fang Xuewen2()
Received:
2023-10-07
Online:
2024-12-20
Published:
2025-01-10
Contact:
Fang Xuewen,Email: CLC Number:
Wang Hongqian, Fang Xuewen. Effects of family-centered advance care planning on ACP readiness and quality of life in patients with advanced cancer[J]. Clinical Focus, 2024, 39(12): 1106-1110.
Add to citation manager EndNote|Ris|BibTeX
URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2024.12.008
组别 | 例数 | 性别 | 年龄(岁) | 婚姻状况 | ||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
男 | 女 | ≤40 | 41~50 | 51~60 | 61~70 | ≥71 | 未婚 | 已婚 | 离异 | 分居 | ||||||||||||||||||||
干预组 | 40 | 23(57.5) | 17(42.5) | 2(5.0) | 3(7.5) | 19(47.5) | 12(30.0) | 4(10.0) | 4(10.0) | 21(52.5) | 10(25.0) | 5(12.5) | ||||||||||||||||||
对照组 | 42 | 25(59.5) | 17(40.5) | 6(14.3) | 5(11.9) | 19(45.2) | 10(23.8) | 2(4.8) | 4(9.5) | 24(57.1) | 9(21.4) | 5(11.9) | ||||||||||||||||||
χ2值 | 0.035 | 3.411 | 0.204 | |||||||||||||||||||||||||||
P值 | 0.852 | 0.492 | 0.977 | |||||||||||||||||||||||||||
组别 | 文化程度 | 医疗费用支付方式 | 居住地 | 有无宗教信仰 | 有无经历或接触过 抢救经经历 | |||||||||||||||||||||||||
小学及以下 | 初中 | 高中及以上 | 自费 | 新农合 | 职工医保 | 居民医保 | 城镇 | 农村 | 有 | 无 | 有 | 无 | ||||||||||||||||||
干预组 | 20(50.0) | 12(30.0) | 8(20.0) | 3(7.5) | 24(60.0) | 6(15.0) | 7(17.5) | 14(35.0) | 26(65.0) | 3(7.5) | 37(92.5) | 13(32.5) | 27(67.5) | |||||||||||||||||
对照组 | 22(52.4) | 15(35.7) | 5(11.9) | 2(4.8) | 22(52.4) | 9(21.4) | 9(21.4) | 10(23.8) | 32(76.2) | 4(9.5) | 38(90.5) | 15(35.7) | 27(64.3) | |||||||||||||||||
χ2值 | 1.677 | 1.094 | 1.239 | 0.108 | 0.094 | |||||||||||||||||||||||||
P值 | 0.700 | 0.778 | 0.266 | 0.743 | 0.759 |
Tab.1 Comparison of general information between groups
组别 | 例数 | 性别 | 年龄(岁) | 婚姻状况 | ||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
男 | 女 | ≤40 | 41~50 | 51~60 | 61~70 | ≥71 | 未婚 | 已婚 | 离异 | 分居 | ||||||||||||||||||||
干预组 | 40 | 23(57.5) | 17(42.5) | 2(5.0) | 3(7.5) | 19(47.5) | 12(30.0) | 4(10.0) | 4(10.0) | 21(52.5) | 10(25.0) | 5(12.5) | ||||||||||||||||||
对照组 | 42 | 25(59.5) | 17(40.5) | 6(14.3) | 5(11.9) | 19(45.2) | 10(23.8) | 2(4.8) | 4(9.5) | 24(57.1) | 9(21.4) | 5(11.9) | ||||||||||||||||||
χ2值 | 0.035 | 3.411 | 0.204 | |||||||||||||||||||||||||||
P值 | 0.852 | 0.492 | 0.977 | |||||||||||||||||||||||||||
组别 | 文化程度 | 医疗费用支付方式 | 居住地 | 有无宗教信仰 | 有无经历或接触过 抢救经经历 | |||||||||||||||||||||||||
小学及以下 | 初中 | 高中及以上 | 自费 | 新农合 | 职工医保 | 居民医保 | 城镇 | 农村 | 有 | 无 | 有 | 无 | ||||||||||||||||||
干预组 | 20(50.0) | 12(30.0) | 8(20.0) | 3(7.5) | 24(60.0) | 6(15.0) | 7(17.5) | 14(35.0) | 26(65.0) | 3(7.5) | 37(92.5) | 13(32.5) | 27(67.5) | |||||||||||||||||
对照组 | 22(52.4) | 15(35.7) | 5(11.9) | 2(4.8) | 22(52.4) | 9(21.4) | 9(21.4) | 10(23.8) | 32(76.2) | 4(9.5) | 38(90.5) | 15(35.7) | 27(64.3) | |||||||||||||||||
χ2值 | 1.677 | 1.094 | 1.239 | 0.108 | 0.094 | |||||||||||||||||||||||||
P值 | 0.700 | 0.778 | 0.266 | 0.743 | 0.759 |
组别 | 例数 | 态度维度 | 信念维度 | 动机维度 | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
干预前 | 干预后1周 | 干预后1月 | 干预前 | 干预后1周 | 干预后1月 | 干预前 | 干预后1周 | 干预后1月 | ||||
干预组 | 40 | 2.80±0.35 | 3.21±0.40* | 3.48±0.33* | 2.75±0.34 | 3.68±0.44* | 3.88±0.41* | 2.79±0.37 | 3.28±0.48* | 3.71±0.35* | ||
对照组 | 42 | 2.71±0.49 | 2.94±0.41 | 3.11±0.49 | 2.69±0.33 | 3.40±0.53 | 3.62±0.43 | 2.87±0.44 | 3.07±0.43 | 3.49±0.40 | ||
组间 | ||||||||||||
时点间 | ||||||||||||
组间·时点间 |
Tab.2 Comparison of the dimension score of ACP readiness between groups after intervention
组别 | 例数 | 态度维度 | 信念维度 | 动机维度 | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
干预前 | 干预后1周 | 干预后1月 | 干预前 | 干预后1周 | 干预后1月 | 干预前 | 干预后1周 | 干预后1月 | ||||
干预组 | 40 | 2.80±0.35 | 3.21±0.40* | 3.48±0.33* | 2.75±0.34 | 3.68±0.44* | 3.88±0.41* | 2.79±0.37 | 3.28±0.48* | 3.71±0.35* | ||
对照组 | 42 | 2.71±0.49 | 2.94±0.41 | 3.11±0.49 | 2.69±0.33 | 3.40±0.53 | 3.62±0.43 | 2.87±0.44 | 3.07±0.43 | 3.49±0.40 | ||
组间 | ||||||||||||
时点间 | ||||||||||||
组间·时点间 |
组别 | 例数 | 角色功能维度 | 情绪功能维度 | 认知功能维度 | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
干预前 | 干预后1周 | 干预后1月 | 干预前 | 干预后1周 | 干预后1月 | 干预前 | 干预后1周 | 干预后1月 | ||||||||
干预组 | 40 | 3.12±0.48 | 2.71±0.53* | 2.48±0.58* | 3.19±0.40 | 2.80±0.49* | 2.44±0.31* | 3.05±0.40 | 2.72±0.44* | 2.58±0.47* | ||||||
对照组 | 42 | 3.02±0.58 | 2.96±0.52 | 2.87±0.56 | 3.24±0.43 | 3.05±0.41 | 2.77±0.55 | 3.16±0.42 | 2.96±0.45 | 2.87±0.49 | ||||||
组间 | ||||||||||||||||
时点间 | ||||||||||||||||
组间·时点间 | ||||||||||||||||
组别 | 社会功能维度 | 生命质量总分 | ||||||||||||||
干预前 | 干预后1周 | 干预后1月 | 干预前 | 干预后1周 | 干预后1月 | |||||||||||
干预组 | 3.09±0.54 | 2.74±0.52* | 2.43±0.42* | 3.15±0.36 | 2.82±0.38* | 2.65±0.32* | ||||||||||
对照组 | 3.13±0.33 | 2.98±0.44 | 2.73±0.50 | 3.11±0.41 | 3.03±0.47 | 2.87±0.46 | ||||||||||
组间 | ||||||||||||||||
时点间 | ||||||||||||||||
组间·时点间 |
Tab.3 Comparison of the total score and some dimension scores of quality of life between groups after intervention
组别 | 例数 | 角色功能维度 | 情绪功能维度 | 认知功能维度 | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
干预前 | 干预后1周 | 干预后1月 | 干预前 | 干预后1周 | 干预后1月 | 干预前 | 干预后1周 | 干预后1月 | ||||||||
干预组 | 40 | 3.12±0.48 | 2.71±0.53* | 2.48±0.58* | 3.19±0.40 | 2.80±0.49* | 2.44±0.31* | 3.05±0.40 | 2.72±0.44* | 2.58±0.47* | ||||||
对照组 | 42 | 3.02±0.58 | 2.96±0.52 | 2.87±0.56 | 3.24±0.43 | 3.05±0.41 | 2.77±0.55 | 3.16±0.42 | 2.96±0.45 | 2.87±0.49 | ||||||
组间 | ||||||||||||||||
时点间 | ||||||||||||||||
组间·时点间 | ||||||||||||||||
组别 | 社会功能维度 | 生命质量总分 | ||||||||||||||
干预前 | 干预后1周 | 干预后1月 | 干预前 | 干预后1周 | 干预后1月 | |||||||||||
干预组 | 3.09±0.54 | 2.74±0.52* | 2.43±0.42* | 3.15±0.36 | 2.82±0.38* | 2.65±0.32* | ||||||||||
对照组 | 3.13±0.33 | 2.98±0.44 | 2.73±0.50 | 3.11±0.41 | 3.03±0.47 | 2.87±0.46 | ||||||||||
组间 | ||||||||||||||||
时点间 | ||||||||||||||||
组间·时点间 |
[1] | 医政医管局. 关于安宁疗护中心基本标准、管理规范及安宁疗护实践指南的解读[EB/OL]. http://www.nhc.gov.cn/yzygj/s3593/201702/f12b1c7868194dd0ba1c658b32f8b59f.shtml, 2017-02-09. |
[2] | 陈园园, 杨潇潇, 孟繁洁. 决策辅助在预立医疗照护计划中的应用进展[J]. 中华现代护理杂志, 2020, 26(5):680-684. |
[3] | 周雯, 倪平, 毛靖. 患者临终决策意愿的研究现况[J]. 护理学杂志, 2016, 31(1):107-109. |
[4] |
王心茹, 绳宇. 预立医疗照护计划在肿瘤患者中的应用进展[J]. 中华护理杂志, 2019, 54(2):306-310.
doi: 10.3761/j.issn.0254-1769.2019.02.029 |
[5] | Wright AA, Keating NL, Nicholas LH. Associations between cancer patients' advance care and financial planning and surviving spouses' financial well-being[J]. J Clin Oncol, 2017, 35(5l):6567. |
[6] | 赵宇飞, 赵素琴. 血液透析患者对预立医疗照护计划的接受程度及其影响因素[J]. 解放军护理杂志, 2018, 36(8):19-22. |
[7] | Li T, Pei X, Chen X, et al. Identifying end-of-life prefe-rences among Chinese patients with cancer using the heart to heart card game[J]. Am J Hosp Palliat Care, 2021, 38 (1):62-67. |
[8] | 美华慈心联盟. 安心茶话屋[EB/OL].http://www.caccc-usa.Org/en/activities/heart2heart.Html, 2018-10-01/2022-01-11. |
[9] | 罗点点. 我的五个愿望[EB/OL].http://www.lwpa.org.cn/Index.shtml, 2009-05-20/2019-10-02. |
[10] | 王心茹. 慢病患者预立医疗照护计划准备度及其影响因素的研究[D]. 北京: 北京协和医学院, 2019. |
[11] |
Movsas B, Moughan J, Sarna L, et al. Quality of life supersedes the classic prognosticators for long-term survival in locally advanced non-small-cell lung cancer: An analysis of RTOG 9801[J]. J Clin Oncol, 2009, 27(34):5816-5822.
doi: 10.1200/JCO.2009.23.7420 pmid: 19858383 |
[12] | Meyer F, Fortin A, Gelinas M, et al. Healthrelated quality of life as a survival predictor for patients with localized head and neck cancer treated with radiation therapy[J]. J Clin Oncol, 2009, 27(18):2970-2976. |
[13] | 万崇华, 陈明清, 张灿珍, 等. 癌症患者生命质量测定量表EORTC QLQ-C30 中文版评介[J]. 实用肿瘤杂志, 2005, (4): 353-355. |
[14] |
邓志坚, 陈相应, 杨柳, 等. 癌症患者及家属参与预立医疗照护计划体验质性研究的Meta整合[J]. 中华护理杂志, 2020, 55(12):1864-1870.
doi: 10.3761/j.issn.0254-1769.2020.12.019 |
[15] | Simon J, Porterfield P, Bouchal SR, et al. ‘Not yet’ and ‘Just ask’: Barriers and facilitators to advance care planning-a qualitative descriptive study of the perspectives of seriously ill, older patients and their families[J]. Bmj Support Palliat Care, 2015, 5(1):54-62. |
[16] | 张娟, 胡玉洁, 潘玉芹, 等. 基于认知适应理论的晚期癌症患者预立医疗照护计划准备度及影响因素研究[J]. 护理学杂志, 2021, 36(8):9-12. |
[17] |
da Rocha Rodrigues MG, Pautex S, Zumstein-Shaha M. Revie ⊕: An intervention promoting the dignity of individuals with advanced cancer: A feasibility study[J]. Eur J Oncol Nurs, 2019, 39:81-89.
doi: S1462-3889(19)30006-7 pmid: 30850142 |
[18] | Cheng SY, Lin SP, Chan HY, et al. Advance care planning in Asian culture[J]. Jpn J Clin Oncol, 2020, 50(9): 976-989. |
[19] |
Lum H, Sudore R, Matlock D, et al. A group visit initiative improves advance care planning documentation among older adults in primary care[J]. J Am Board Fam Med, 2017, 30(4):480-490.
doi: 10.3122/jabfm.2017.04.170036 pmid: 28720629 |
[20] |
李豪, 景孟娟, 徐榆林, 等. 预立医疗照护计划在血液透析患者中的应用研究[J]. 中华护理杂志, 2022, 57(6):645-650.
doi: 10.3761/j.issn.0254-1769.2022.06.001 |
[1] | Guo Xiaocui, Yu Xiaojuan, Shen Xia, Ye Shuiying, Zhou Dongchi, Lai Bihong. Effect of a multidisciplinary intervention on the quality of life in maintenance hemodialysis patients [J]. Clinical Focus, 2024, 39(9): 803-807. |
[2] | Liu Jiazhu, Liu Rong, Meng Limin, Guo Yinshu, Zhang Xiaobo, Ai Yiqin. Systematic evaluation of the incidence and the influencing factors of sleep disorders in breast cancer patients [J]. Clinical Focus, 2024, 39(6): 494-500. |
[3] | Gao Ming, Liu Hao, Yu Hang, Lin Lin, Zhang Zijie, Xiong Ying. Diagnostic value of contrast-enhanced ultrasound in differentiating focal testicular lesions: A meta-analysis [J]. Clinical Focus, 2024, 39(5): 389-395. |
[4] | Wu Xiaomin, Fang Yipeng, Zhang Zhen, Zhang Ye, Jin Cheng. Clinical application of GEMOX combined with target-immunity therapy in patients with advanced biliary tract cancer [J]. Clinical Focus, 2024, 39(5): 408-412. |
[5] | Wang Ting, Chai Chunyan. Application of vericiguat in elderly patients with heart failure with reduced ejection fraction [J]. Clinical Focus, 2024, 39(12): 1081-1084. |
[6] | Wu Zhouwen, He Xinyi. Impact of stylistic training on the coping style and quality of life of schizophrenia patients during the rehabilitation period [J]. Clinical Focus, 2024, 39(12): 1085-1088. |
[7] | Zhao Jinxia, Kang Huihui, Zhang Yao, Fu Shengjun, Sun Pengfei. Correlation between serum lipids before radical gastrectomy for gastric cancer and the prognosis [J]. Clinical Focus, 2024, 39(10): 889-895. |
[8] | Li Zhenan, Zhu Xuejuan, Li Shang, Wang Junmin. Effect of glucocorticoids with varied courses on the prevention of esophageal stricture after esophageal submucosal dissection [J]. Clinical Focus, 2024, 39(10): 896-900. |
[9] | Liu Jing, Liu Lianpei, Zhang Mengmeng, Chai Linlin, Li Rong, Zhu Liying. Gastric adenocarcinoma of fundic gland type: A case report and literature review [J]. Clinical Focus, 2024, 39(10): 929-934. |
[10] | Huang Saihu, Long Zhongjie, Dong Xingqiang, Meng Xiangying, Wu Shuiyan, Bai Zhenjiang. Pathogen and clinical characteristics of children with hematologic neoplasms complicated with sepsis [J]. Clinical Focus, 2024, 39(1): 38-42. |
[11] | Zhao Xuhui, Huang Xiaomin, Da Dezhuan, Xu Yan, Cui Xiaodong, Li Hongling. Screening of glycolysis-related genes for predicting the prognosis of patients with gastric cancer: Based on bioinformatics [J]. Clinical Focus, 2024, 39(1): 20-29. |
[12] | Lyu Chang, Zhou Liming. Correlation between the TNF-α-308 gene polymorphism and gastric cancer susceptibility: A meta-analysis [J]. Clinical Focus, 2023, 38(9): 779-787. |
[13] | You Yi, Gao Shuqing, Xu Hao. Effect of enteral nutrition on postoperative clinical outcome of esophageal neoplasms: A meta-analysis [J]. Clinical Focus, 2023, 38(6): 485-492. |
[14] | Li Ya, Du Taoming, Qiu Shixiang, Chen Chao, Zhong Liming. Study on brain functional connectivity in patients with liver cancer with depression [J]. Clinical Focus, 2023, 38(6): 532-536. |
[15] | Wang Yingnan, Zhao Qi, Bai Haiwei, Wu Danna, Wei Jinmei, Li Shengjiang, Li Ruiling, Zhang Ruixing. Clinical characteristics and risk factors of gastric cancer-related stroke [J]. Clinical Focus, 2023, 38(5): 417-422. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||